Citrin Cooperman Acquires Browne Consulting Group to Expand Life Sciences Advisory

Why It Matters

The purchase deepens Citrin’s specialization in a high‑growth, regulation‑intensive sector, positioning the firm to capture more lucrative biotech advisory work. It also signals continued consolidation among accounting firms targeting niche industries.

Key Takeaways

• Citrin acquires Browne Consulting, adding 60 professionals
• Strengthens Boston presence in life sciences advisory
• Expands service offering for biotech startups, pre‑seed to Series A
• Marks Citrin’s first M&A deal of 2026
• Adds to firm’s 30+ acquisitions since 2019

Pulse Analysis

The accounting industry has entered a phase of strategic consolidation, with firms seeking to augment niche capabilities that align with high‑margin markets. Life sciences and biotech, driven by robust venture capital inflows and complex regulatory landscapes, have become prime targets for advisory services. By integrating Browne Consulting, Citrin Cooperman taps into a specialized talent pool that can navigate the financial, operational, and human‑resource challenges unique to early‑stage biotech firms, thereby enhancing its value proposition beyond traditional audit work.

Citrin’s Boston expansion is more than geographic; it represents a deliberate move to embed itself within the innovation hub of the Northeast. The combined entity can now offer end‑to‑end solutions—from operational accounting for pre‑seed startups to strategic finance for Series A and beyond—leveraging Browne’s deep sector knowledge and Citrin’s national network. Clients benefit from a unified platform that delivers industry‑specific insights, regulatory compliance guidance, and scalable advisory support as they transition from research to commercialization.

Looking ahead, the deal underscores a broader trend of accounting firms pursuing sector‑focused growth through M&A. As biotech continues to attract funding and regulatory scrutiny intensifies, firms that can provide tailored, high‑touch services will command premium fees. Citrin’s track record of over 30 acquisitions since 2019 positions it to further consolidate expertise, potentially sparking additional partnerships in adjacent high‑growth verticals such as health‑tech and med‑device. This strategic momentum is likely to reshape competitive dynamics, rewarding firms that blend deep industry knowledge with expansive advisory capabilities.

Deal Summary

Citrin Cooperman, a top‑20 accounting firm, announced on Feb. 10, 2026 that it has acquired Boston‑based Browne Consulting Group, which provides accounting and advisory services to life‑science and biotech firms. The terms were not disclosed. The deal adds about 60 professionals and strengthens Citrin Cooperman’s presence in the life‑science sector.